AP – USA regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses.
The Food and Drug Administration on Friday delivered advances to the naloxone spray from Israel's Teva Pharmaceuticals.
Naloxon has been sold as a nasal spray in the United States since 2016 under the Narcan brand. Pharmacists can dispense it without a prescription. It is also sold as a generic or brand name substance in automatic injectors, pre-filled syringes and vials.
A package of two Narcan nasal sprays costs about $ 1
More than 47,600 Americans died of opioid overdoses in 2017, a toll that has risen for two decades.